Pabatang, Zedric Angelo .

HRN: 21-82-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 750MG (VIAL)
12/16/2023
12/22/2023
IV
370mg
Q8h
T/c UTI
Checking Final Appropriateness 
12/17/2023
CEFUROXIME 1.5GM (VIAL)
12/17/2023
12/23/2023
IV
366mg
Q8
UTI; Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: